Keebeck Alpha, LP Stryker Corp Transaction History

Keebeck Alpha, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$293.94 - $358.71 $285,415 - $348,307	971 New	971 $347,000
Q3 2023 Nov 02, 2023	SELL	$266.54 - $302.43 $84,759 - $96,172	-318 Reduced 20.88%	1,205 $329,000
Q2 2023 Jul 25, 2023	BUY	$271.49 - $305.09 $166,423 - $187,020	613 Added 67.36%	1,523 $464,000
Q1 2023 May 11, 2023	BUY	$246.13 - $285.47 $223,978 - $259,777	910 New	910 $259,000
Q3 2020 Nov 02, 2020	SELL	$177.77 - $215.81 $286,743 - $348,101	-1,613 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$144.67 - $207.03 $233,352 - $333,939	1,613 New	1,613 $291,000

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $137B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.